Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 3689
Selected: 0
NCT IDTitle
NCT01414881Study to Assess the Effects of Mipomersen on Lipid and Lipoprotein Metabolism in Healthy Subjects
NCT00552565Efficacy Study of Rezular (Arverapamil) in the Treatment of Irritable Bowel Syndrome With Diarrhea (IBS-D)
NCT01521065An Open-label Study to Evaluate the Clinical and Economic Benefits of I-Ray in Patients With Choroidal Neovascularization Secondary to Age-related Macular Degeneration
NCT02436707Novel Combination Therapy in the Treatment of Relapsed and Refractory Aggressive B-Cell Lymphoma
NCT02341807Safety and Dose-escalation Study of AAV2-hCHM in Participants With CHM (Choroideremia) Gene Mutations
NCT01228071Time to Eugonadal Range, Time to Steady State and Drying Time
NCT05986864Phase I/II Study of SKG0106 Intravitreal Injection in Patients With Neovascular Age-related Macular Degeneration (nAMD)
NCT06019000Study of CYR-064 Versus Placebo in Patients.
NCT00043836The DIAMOND Study: Distensibility Improvement And Remodeling in Diastolic Heart Failure
NCT04973111A Study to Assess CT-868 and the Relationship Between Insulin Secretory Response and Ambient Blood Glucose
NCT03500263Safety, Tolerability, and Pharmacokinetics of PTI-808, PTI-801, and PTI-428 Combination Therapy in Subjects With Cystic Fibrosis
NCT02156063A Multi-center, Placebo-controlled Study to Evaluate NT100 in Pregnant Women With a History of Unexplained Recurrent Pregnancy Loss (RPL)
NCT05877963Study to Evaluate Safety, Efficacy and Pharmacokinetics (PK) of a Modified Regimen of Ublituximab
NCT00671814Single and Multiple Ascending Dose Pharmacokinetic Study of TR701 in Healthy Adults
NCT04616430Topical Endoxifen in Women
NCT00958334Extension Study of Proellex in Women Who Have Previously Completed Study ZPU 003
NCT02938507Evaluate the Safety, Tolerability and PK of Different Formulations of Orally Administered Solabegron in Healthy Male Subjects
NCT06817863A Self-Guided Mobile Intervention for Adults With Binge Eating and Obesity
NCT00425178FGF-1 for Topical Administration for the Treatment of Diabetic or Venous Stasis Ulcers
NCT05759949First-in-Human Study of RLY-5836 in Advanced Breast Cancer and Other Solid Tumors
NCT03337308A Study Evaluating the Safety and Efficacy of Bempedoic Acid Plus Ezetimibe Fixed-Dose Combination Compared to Bempedoic Acid, Ezetimibe, and Placebo in Patients Treated With Maximally Tolerated Statin Therapy
NCT04562389Study of Selinexor in Combination With Ruxolitinib in Myelofibrosis
NCT04993768A Phase 2a Study of TPN-101 in Patients With Progressive Supranuclear Palsy (PSP)
NCT00159250Safety and Efficacy Study of Antisense Oligonucleotides in Duchenne Muscular Dystrophy
NCT06400485AMT-676 in Patients With Advanced Solid Tumors
NCT05893043A Study of Multiple Ascending Doses of GSBR-1290 in Japanese and Non-Japanese Healthy Participants
NCT06493578A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of VYN201 Gel in Subjects With Non-segmental Vitiligo.
NCT01020708Study of the Safety and Tolerability of ALTH12 Versus Mesalamine Enema in Subjects With Left-Sided Ulcerative Colitis
NCT05255276PK Study to Assess Drug-drug Interaction Between Sitravatinib and a P-gp Inducer and an Inhibitor.
NCT03675685Safety and Pharmacokinetics of a Single Dose of CCH (3.36 mg) in Subjects With EFP
NCT02427308Treatment of Leishmaniasis With Impavido® (Miltefosine): Pregnancy Registry
NCT04023721Evaluating the Safety and Efficacy of Inarigivir in Non-cirrhotic, Hepatitis B e Antigen-negative Subjects Infected With HBV Virus and Receiving or Stopping Treatment With a NUC Inhibitor
NCT04045769A Study to Evaluate the Effect of Saroglitazar Magnesium on the QTc Interval in Healthy Volunteers
NCT05432466Clinical Trial to Compare the Efficacy of Celiprolol to Placebo in Patients With Vascular Ehlers-Danlos Syndrome
NCT07148180A Multi-Site Break Through Cancer Trial: Targeting Measurable Residual Disease in Patients With Acute Myeloid Leukemia: A Phase 1/2 Study of Tagraxofusp, Azacitidine, and Venetoclax
NCT00492596The AttenueX IntraVesical System for the Treatment of Female Stress Urinary Incontinence
NCT00014131Vaccine Therapy in Treating Patients With Kidney Cancer
NCT06976268A Study to Determine if BHV-8000 is Effective, Safe and Tolerable as a Treatment for Adults Living With Early Parkinson's Disease
NCT07103746Ublituximab in Autoantibody Positive Immune Mediated Necrotizing Myopathy
NCT04485260An Open-Label, Multicenter, Phase 1b/2 Study of the Safety and Efficacy of KRT-232 Combined With Ruxolitinib in Patients With Primary Myelofibrosis (PMF), Post-Polycythemia Vera MF (Post-PV-MF), Or Post-Essential Thrombocythemia MF (Post ET-MF) Who Have a Suboptimal Response to Ruxolitinib
NCT07262268A Phase 1b Study of BHV-7000 in Participants With Inherited Erythromelalgia
NCT05401110Study of Osimertinib With Carotuximab in Advanced, EGFR-mutated Non-Small Cell Lung Cancer
NCT06241950A Gene Transfer Therapy Study to Evaluate the Safety and Efficacy of Delandistrogene Moxeparvovec (SRP-9001) Following Imlifidase Infusion in Participants With Duchenne Muscular Dystrophy (DMD) Determined to Have Pre-existing Antibodies to Recombinant Adeno-Associated Virus Serotype (rAAVrh74)
NCT06917079BBO-11818 in Adult Subjects With KRAS Mutant Cancer
NCT06009003Individual Patient Esmethadone (REL-1017) Expanded Access Program
NCT07593456NST-SPARK Open-Label Phase 1 STTR (IGNITE)
NCT04112446Study to Evaluate Absorption, Metabolism and Excretion of Single-dose [14C]-Saroglitazar in Healthy Male Subjects
NCT04617054Phase II Study of AB-106 to Treat Patients With Solid Tumors With NTRK Gene Fusion
NCT06525935A Study of Enicepatide (CT-388) in Participants With Obesity or Overweight With at Least One Weight-Related Comorbidity
NCT05936489Plasma Pharmacokinetics and Safety of LNZ101 and LNZ100 Ophthalmic Solutions in Healthy Adult Subjects With Presbyopia